Polaris Group (TPE:6550) Gross Margin %: -1,899.75% (As of Dec. 2025)


TPE:6550 Polaris Group TPE:6550
56 GF Score
Price NT$13.55
GF Value NT$55.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Polaris Group Gross Margin %?

Polaris Group TPE:6550 +2.26% 56 Gross Margin % is -1,899.75% as of Dec. 2025. GuruFocus rates TPE:6550 with a GF Score™ of 56/100 and a GF Value™ of NT$55.10 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 735 Biotechnology companies, Polaris Group ranks worse than 98.5% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Polaris Group's Gross Profit for the three months ended in Dec. 2025 was NT$-114.33 Mil. Polaris Group's Revenue for the three months ended in Dec. 2025 was NT$6.02 Mil. Therefore, Polaris Group's Gross Margin % for the quarter that ended in Dec. 2025 was -1,899.75%.


The historical rank and industry rank for Polaris Group's Gross Margin % or its related term are showing as below:

TPE:6550' s Gross Margin % Range Over the Past 10 Years
Min: -665.79   Med: -13.52   Max: 25.83
Current: -665.79


During the past 12 years, the highest Gross Margin % of Polaris Group was 25.83%. The lowest was -665.79%. And the median was -13.52%.

TPE:6550's Gross Margin % is ranked worse than
98.5% of 735 companies
in the Biotechnology industry
Industry Median: 60.9 vs TPE:6550: -665.79

Polaris Group had a gross margin of -1,899.75% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Polaris Group was 0.00% per year.


Polaris Group  (TPE:6550) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Polaris Group had a gross margin of -1,899.75% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Polaris Group Gross Margin % Related Terms


Polaris Group Gross Margin % Historical Data

* Premium members only.

The historical data trend for Polaris Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polaris Group Gross Margin % Chart

Polaris Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.94 21.98 -40.97 -71.89 -665.79

Polaris Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.37 -473.30 -746.43 -300.61 -1,899.75

TPE:6550 vs VRTX, REGN, ALNY: Gross Margin % Comparison

For the Biotechnology subindustry, Polaris Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris Group Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Polaris Group's Gross Margin % falls into.


TPE:6550
56GF Score
Polaris Group TPE:6550
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polaris Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Polaris Group's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-270.3 / 40.602
=(Revenue - Cost of Goods Sold) / Revenue
=(40.602 - 310.926) / 40.602
=-665.79 %

Polaris Group's Gross Margin for the quarter that ended in Dec. 2025 is calculated as


Gross Margin % (Q: Dec. 2025 )=Gross Profit (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-114.3 / 6.018
=(Revenue - Cost of Goods Sold) / Revenue
=(6.018 - 120.345) / 6.018
=-1,899.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of -1,899.75% mean?
Polaris Group (TPE:6550) has a Gross Margin % of -1,899.75% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Polaris Group and its competitors. According to the industry distribution chart, Polaris Group ranks #724 out of 735 companies in the Biotechnology industry, placing it in the top 98.5%.
Is Polaris Group's Gross Margin % too high?
Polaris Group's current Gross Margin % is -1,899.75%. Based on the distribution chart, Polaris Group ranks #724 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Polaris Group has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polaris Group's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Polaris Group ranks #724 out of 735 companies for Gross Margin %. This places Polaris Group in the lower half of its industry. The industry median Gross Margin % is 60.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Polaris Group and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polaris Group's current Gross Margin % is -1,899.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polaris Group stock overvalued right now?
Based on GuruFocus' analysis, Polaris Group (TPE:6550) is currently considered Possible Value Trap. The stock's GF Value™ is NT$55.10, compared to a current price of NT$13.55 — trading 75.4% below its estimated fair value. The current Gross Margin % is -1,899.75%. Polaris Group's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Polaris Group (TPE:6550), the current Gross Margin % is -1,899.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polaris Group (TPE:6550) Overvalued in 2026?

Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued. The current stock price of NT$13.55 is trading 75.4% below its estimated GF Value™ of NT$55.10. GuruFocus considers Polaris Group to be Possible Value Trap.

Key valuation signals for TPE:6550:

  • Gross Margin %: -1,899.75%
  • GF Value™: NT$55.10 vs. price of NT$13.55 (75.4% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Polaris Group Business Description

Address Ugland House, PO Box 309, Grand Cayman, CYM, KY1-1104
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
56GF Score

Get the complete analysis for TPE:6550

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.55
Price
NT$55.10
GF Value